How Did the Medicare $35 Insulin Cap Affect Costs, Adherence in Diabetes?

Out-of-pocket medication costs can influence whether patients obtain and consistently use prescribed therapies. For Medicare beneficiaries who use insulin, the Inflation Reduction Act introduced a $35 out-of-pocket cap per 30-day supply in 2023. This quiz series reviews the relationship between insulin affordability and insulin use, with attention to how reduced cost-sharing may affect fills, adherence, and persistence among patients facing high baseline insulin costs.

©2026 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of Consultant360 or HMP Global, their employees, and affiliates.